SMTL ID : 6zzn.1

Crystal structure of the cubic catalytic core of the Mycobacterium tuberculosis branched-chain alphaketoacid acyltransferase component (E2b).

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

homo-24-mer

Ligands

48 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 3 residues within 4Å: Chain A: R.44, P.56 Ligands: ACT.2 Ligand excluded by PLIP ACT.2: 6 residues within 4Å: Chain A: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.1 Ligand excluded by PLIP ACT.4: 3 residues within 4Å: Chain B: R.44, P.56 Ligands: ACT.5 Ligand excluded by PLIP ACT.5: 6 residues within 4Å: Chain B: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.4 Ligand excluded by PLIP ACT.7: 3 residues within 4Å: Chain C: R.44, P.56 Ligands: ACT.8 Ligand excluded by PLIP ACT.8: 6 residues within 4Å: Chain C: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.7 Ligand excluded by PLIP ACT.10: 3 residues within 4Å: Chain D: R.44, P.56 Ligands: ACT.11 Ligand excluded by PLIP ACT.11: 6 residues within 4Å: Chain D: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.10 Ligand excluded by PLIP ACT.13: 3 residues within 4Å: Chain E: R.44, P.56 Ligands: ACT.14 Ligand excluded by PLIP ACT.14: 6 residues within 4Å: Chain E: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.13 Ligand excluded by PLIP ACT.16: 3 residues within 4Å: Chain F: R.44, P.56 Ligands: ACT.17 Ligand excluded by PLIP ACT.17: 6 residues within 4Å: Chain F: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.16 Ligand excluded by PLIP ACT.19: 3 residues within 4Å: Chain G: R.44, P.56 Ligands: ACT.20 Ligand excluded by PLIP ACT.20: 6 residues within 4Å: Chain G: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.19 Ligand excluded by PLIP ACT.22: 3 residues within 4Å: Chain H: R.44, P.56 Ligands: ACT.23 Ligand excluded by PLIP ACT.23: 6 residues within 4Å: Chain H: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.22 Ligand excluded by PLIP ACT.25: 3 residues within 4Å: Chain I: R.44, P.56 Ligands: ACT.26 Ligand excluded by PLIP ACT.26: 6 residues within 4Å: Chain I: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.25 Ligand excluded by PLIP ACT.28: 3 residues within 4Å: Chain J: R.44, P.56 Ligands: ACT.29 Ligand excluded by PLIP ACT.29: 6 residues within 4Å: Chain J: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.28 Ligand excluded by PLIP ACT.31: 3 residues within 4Å: Chain K: R.44, P.56 Ligands: ACT.32 Ligand excluded by PLIP ACT.32: 6 residues within 4Å: Chain K: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.31 Ligand excluded by PLIP ACT.34: 3 residues within 4Å: Chain L: R.44, P.56 Ligands: ACT.35 Ligand excluded by PLIP ACT.35: 6 residues within 4Å: Chain L: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.34 Ligand excluded by PLIP ACT.37: 3 residues within 4Å: Chain M: R.44, P.56 Ligands: ACT.38 Ligand excluded by PLIP ACT.38: 6 residues within 4Å: Chain M: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.37 Ligand excluded by PLIP ACT.40: 3 residues within 4Å: Chain N: R.44, P.56 Ligands: ACT.41 Ligand excluded by PLIP ACT.41: 6 residues within 4Å: Chain N: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.40 Ligand excluded by PLIP ACT.43: 3 residues within 4Å: Chain O: R.44, P.56 Ligands: ACT.44 Ligand excluded by PLIP ACT.44: 6 residues within 4Å: Chain O: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.43 Ligand excluded by PLIP ACT.46: 3 residues within 4Å: Chain P: R.44, P.56 Ligands: ACT.47 Ligand excluded by PLIP ACT.47: 6 residues within 4Å: Chain P: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.46 Ligand excluded by PLIP ACT.49: 3 residues within 4Å: Chain Q: R.44, P.56 Ligands: ACT.50 Ligand excluded by PLIP ACT.50: 6 residues within 4Å: Chain Q: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.49 Ligand excluded by PLIP ACT.52: 3 residues within 4Å: Chain R: R.44, P.56 Ligands: ACT.53 Ligand excluded by PLIP ACT.53: 6 residues within 4Å: Chain R: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.52 Ligand excluded by PLIP ACT.55: 3 residues within 4Å: Chain S: R.44, P.56 Ligands: ACT.56 Ligand excluded by PLIP ACT.56: 6 residues within 4Å: Chain S: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.55 Ligand excluded by PLIP ACT.58: 3 residues within 4Å: Chain T: R.44, P.56 Ligands: ACT.59 Ligand excluded by PLIP ACT.59: 6 residues within 4Å: Chain T: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.58 Ligand excluded by PLIP ACT.61: 3 residues within 4Å: Chain U: R.44, P.56 Ligands: ACT.62 Ligand excluded by PLIP ACT.62: 6 residues within 4Å: Chain U: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.61 Ligand excluded by PLIP ACT.64: 3 residues within 4Å: Chain V: R.44, P.56 Ligands: ACT.65 Ligand excluded by PLIP ACT.65: 6 residues within 4Å: Chain V: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.64 Ligand excluded by PLIP ACT.67: 3 residues within 4Å: Chain W: R.44, P.56 Ligands: ACT.68 Ligand excluded by PLIP ACT.68: 6 residues within 4Å: Chain W: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.67 Ligand excluded by PLIP ACT.70: 3 residues within 4Å: Chain X: R.44, P.56 Ligands: ACT.71 Ligand excluded by PLIP ACT.71: 6 residues within 4Å: Chain X: G.153, A.154, G.175, A.176, I.177 Ligands: ACT.70 Ligand excluded by PLIP

24 x IMD: IMIDAZOLE(Non-covalent)

IMD.3: 8 residues within 4Å: Chain A: S.150, F.152, V.161, P.162 Chain I: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.6: 8 residues within 4Å: Chain B: S.150, F.152, V.161, P.162 Chain L: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.9: 8 residues within 4Å: Chain C: S.150, F.152, V.161, P.162 Chain J: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.12: 8 residues within 4Å: Chain D: S.150, F.152, V.161, P.162 Chain K: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.15: 8 residues within 4Å: Chain A: K.30, A.31, F.200, G.207 Chain E: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.18: 8 residues within 4Å: Chain D: K.30, A.31, F.200, G.207 Chain F: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.21: 8 residues within 4Å: Chain B: K.30, A.31, F.200, G.207 Chain G: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.24: 8 residues within 4Å: Chain C: K.30, A.31, F.200, G.207 Chain H: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.27: 8 residues within 4Å: Chain E: K.30, A.31, F.200, G.207 Chain I: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.30: 8 residues within 4Å: Chain H: K.30, A.31, F.200, G.207 Chain J: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.33: 8 residues within 4Å: Chain F: K.30, A.31, F.200, G.207 Chain K: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.36: 8 residues within 4Å: Chain G: K.30, A.31, F.200, G.207 Chain L: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.39: 8 residues within 4Å: Chain M: S.150, F.152, V.161, P.162 Chain U: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.42: 8 residues within 4Å: Chain N: S.150, F.152, V.161, P.162 Chain X: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.45: 8 residues within 4Å: Chain O: S.150, F.152, V.161, P.162 Chain V: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.48: 8 residues within 4Å: Chain P: S.150, F.152, V.161, P.162 Chain W: K.30, A.31, F.200, G.207 Ligand excluded by PLIP IMD.51: 8 residues within 4Å: Chain M: K.30, A.31, F.200, G.207 Chain Q: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.54: 8 residues within 4Å: Chain P: K.30, A.31, F.200, G.207 Chain R: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.57: 8 residues within 4Å: Chain N: K.30, A.31, F.200, G.207 Chain S: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.60: 8 residues within 4Å: Chain O: K.30, A.31, F.200, G.207 Chain T: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.63: 8 residues within 4Å: Chain Q: K.30, A.31, F.200, G.207 Chain U: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.66: 8 residues within 4Å: Chain T: K.30, A.31, F.200, G.207 Chain V: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.69: 8 residues within 4Å: Chain R: K.30, A.31, F.200, G.207 Chain W: S.150, F.152, V.161, P.162 Ligand excluded by PLIP IMD.72: 8 residues within 4Å: Chain S: K.30, A.31, F.200, G.207 Chain X: S.150, F.152, V.161, P.162 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bruch, E.M. et al., Actinobacteria challenge the paradigm: A unique protein architecture for a well-known, central metabolic complex. Proc.Natl.Acad.Sci.USA (2021)

Release Date

2021-08-18

Peptides

Dihydrolipoyllysine-residue acyltransferase component of branched-chain alpha-ketoacid dehydrogenase complex: ABCDEFGHIJKLMNOPQRSTUVWX

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

E
A

F
A

G
A

H
A

I
A

J
A

K
A

L
A

M
A

N
A

O
A

P
A

Q
A

R
A

S
A

T
A

U
A

V
A

W
A

X
A

Dihydrolipoyllysine-residue acyltransferase component of branched-chain alpha-ketoacid dehydrogenase complex